With Tesla stock stuck recently, investor attention turns to next week's earnings report.

WTI crude oil holds the 200-day MA, but soft demand and resistance at $67.44 cap upside. Read this oil outlook and analysis of key technical drivers.

The property and casualty insurer reports core earnings of $6.51 a share for the second quarter.

US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly to cash-paying patients at discounted rate through a new program.

Making its debut on 04/19/2011, smart beta exchange traded fund First Trust Mid Cap Value AlphaDEX ETF (FNK) provides investors broad exposure to the Style Box - Mid Cap Value category of the market.

Designed to provide broad exposure to the Style Box - All Cap Growth category of the market, the American Century U.S. Quality Growth ETF (QGRO) is a smart beta exchange traded fund launched on 09/10/2018.

Designed to provide broad exposure to the Industrials ETFs category of the market, the SPDR S&P Aerospace & Defense ETF (XAR) is a smart beta exchange traded fund launched on 09/28/2011.

The Fidelity Value Factor ETF (FVAL) was launched on 09/12/2016, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Value category of the market.

Looking for broad exposure to the Small Cap Blend segment of the US equity market? You should consider the iShares Russell 2000 ETF (IWM), a passively managed exchange traded fund launched on 05/22/2000.

Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) is a passively managed exchange traded fund launched on 12/30/2016.

When it comes to earnings season, few sectors matter as much as the financial sector. Considering that banks, both commercial and investment banks, hold the bulk of data on consumer and business activity, it is essential for investors to monitor what is being reported and its implications for the broader United States economy, as well as the average consumer.

Designed to provide broad exposure to the Large Cap Value segment of the US equity market, the Invesco RAFI US 1000 ETF (PRF) is a passively managed exchange traded fund launched on 12/19/2005.

Designed to provide broad exposure to the Large Cap Growth segment of the US equity market, the Invesco Russell 1000 Dynamic Multifactor ETF (OMFL) is a passively managed exchange traded fund launched on 11/08/2017.

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Invesco S&P SmallCap 600 Pure Value ETF (RZV), a passively managed exchange traded fund launched on 03/01/2006.

In a recent interview hosted by Webber Research & Advisory, Jerry Kalogiratos, CEO of Capital Clean Energy Carriers Corp. CCEC, provided a detailed overview of the company's strategic pivot to LNG shipping, its growth trajectory, and the broader market dynamics shaping the sector. The discussion, led by Michael Webber, Managing Partner at Webber Research and Advisory, explored long-term market fundamentals, fleet deployment strategy, capital structure, trading liquidity, and emerging trends such as the role of portfolio players and the rising importance of floating storage.

A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, …

Talkspace is the largest in-network telehealth mental health provider in the US, benefiting from strong demand and a scalable, flexible clinician model. The strategic shift to a payor model has driven rapid revenue growth, improved profitability, and created a more attractive, affordable consumer offering. Financials are robust: 15%+ revenue growth, strong operating leverage, GAAP profitability, a fortress balance sheet, and active share buybacks support the investment case.

CNBC's Becky Quick reports on the latest news.

I rate IDEXX Laboratories a buy, driven by a lasting surge in pet ownership and IDXX's leadership in veterinary diagnostics. New platforms like inVue Dx and Cancer Dx provide additional growth drivers, with strong early adoption and potential for margin expansion. IDXX's recurring revenue model, robust retention, and expanding high-margin consumables base support sustained revenue and earnings growth.

DURHAM, N.C., July 17, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading fully integrated site organization, has announced a strategic partnership with Palantir Technologies (“Palantir”) to automate and streamline the notoriously complex payments reconciliation process in clinical trials.